← SynDRA
GSK-461364
SynDRA canonical compound SYN0028186 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | PLK1 |
| Mechanism of action | PLK inhibitor |
All known targets
Mechanisms of action (all sources)
- PLK inhibitor
- PLK1 INHIBITOR
- Serine/threonine-protein kinase PLK1 inhibitor
Cross-references
Synonyms
- GSK-461364A
- GSK461364
- GSK 461364
- 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1h-benzimidazol-1-yl]-3-[(1r)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide
- UNII-8QO27TK6Q4
- GSK 461364A
- (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide
- 8QO27TK6Q4
- CHEMBL1908394
- GSK461364A
- ZHJGWYRLJUCMRT-QGZVFWFLSA-N
- SCHEMBL310080
- GTPL5684
- C27H28F3N5O2S
- CTK8B7590
- CHEBI:91333
- DTXSID60239197
- MolPort-016-633-304
- BCP01720
- 2-Thiophenecarboxamide, 5-(6-((4-methyl-1-piperazinyl)methyl)-1H-benzimidazol-1-yl)-3-((1R)-1-(2-(trifluoromethyl)phenyl)ethoxy)-
- 5-(6-((4-Methylpiperazin-1-yl)methyl)-1H-benzimidazol-1-yl)-3-(((1R)-1-(2-(trifluoromethyl)phenyl)ethyl)oxy)thiophene-2-carboxamide
- 2-THIOPHENECARBOXAMIDE, 5-[6-[(4-METHYL-1-PIPERAZINYL)METHYL]-1H-BENZIMIDAZOL-1-YL]-3-[(1R)-1-[2-(TRIFLUOROMETHYL)PHENYL]ETHOXY]-
- 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide
- GSK41364A
- EX-A1728
- BDBM50355500
- MFCD12755419
- NSC754354
- NSC800111
- s2193
- ZINC43154472
- GSK-461364 [WHO-DD]
- AKOS015904545
- BCP9000744
- CCG-264940
- CS-0069
- NSC-754354
- NSC-800111
Look up GSK-461364 in the interactive SynDRA portal →